Biotech Startups

NanoMedical Systems develops subcutaneous implantable drug-delivery devices built on its nStrada nanofluidics platform, which uses arrays of precision nanochannels to provide long-term, constant release of small molecules, peptides, and proteins for chronic therapies. The platform, manufactured with semiconductor methods, offers passive, refillable, and remotely controlled delivery systems for pharmaceutical and biologic drug delivery.

1 investor

NanoProX develops bismuth sulfide (Bi₂S₃) nanoparticles administered intravenously before radiotherapy to selectively accumulate in tumors and amplify local radiation dose, aiming to increase tumor cell elimination per session without new equipment. The company targets oncology treatment and works with research institutions and clinical centers on preclinical and clinical translation.

1 investor

Nanoptima develops drug delivery technologies for ophthalmic applications, focusing on biomaterial-based solutions for retinal and eye diseases. The company draws on deep pharma and biotech expertise to advance formulation science and delivery mechanisms for pharmaceutical treatments.

1 investor

Nanordica Medical develops the Nanordica Advanced Antibacterial Wound Dressing, a sterile single-use dressing made of natural silk nanofibers with antibacterial nanoparticles (Premotiv technology) that prevents infection and promotes healing of chronic and infected wounds such as diabetic foot ulcers. The Estonian medtech company, a spin-off of the National Institute of Chemical Physics and Biophysics, serves wound-care and clinical settings.

1 investor

NanoScoping is a Brazilian biotechnology company that uses its nTechnology nanotechnology platform to develop biocompatible, biodegradable active ingredients with properties like prolonged release and better penetration. Its inputs serve the cosmetics, veterinary dermatology, nutritional supplement, and agricultural sectors.

1 investor

Nanospectra Biosciences is a medical device company developing nanoparticle-based thermal ablation therapy that uses light-activated nanoshells to destroy solid tumors, such as prostate cancer, while sparing healthy tissue. Its technology targets clinical applications in tumor ablation, tissue treatment, and drug delivery.

1 investor

NanoSuit株式会社 develops the Japan-originated NanoSuit® method, a technology that enables electron microscope observation of living organisms, fixed specimens, cells, and biological particles such as viruses and exosomes in a wet or living state with minimal changes to fine structures. Spun out from Hamamatsu University School of Medicine research, it targets applications in life sciences, healthcare, cosmetics, and food.

1 investor

NanoTess is a social enterprise developing catalytic materials to address wound care and skin health challenges, with a focus on making healthcare technologies accessible and affordable for patients and communities globally.

1 investor

Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.

1 investor

Nanovis develops and manufactures nanoscale surface technologies designed to improve the integration of orthopedic, spinal, and dental implants. It supplies these implant surface technologies to medical device makers and OEM partners in the medtech industry.

1 investor

ImmunityBio develops investigational immunotherapies that activate both innate and adaptive immune responses—stimulating NK cells, T cells, macrophages, and dendritic cells—to treat cancer and infectious diseases. The company works on cell therapies and potential cancer vaccines intended to reduce reliance on high-dose chemotherapy.

1 investor

Clinical-stage biopharmaceutical company developing oligonucleotide therapeutics using an immune cell-targeted delivery platform.

1 investor

Narrativa provides generative AI automation for medical writing, focused on drafting patient safety narratives and clinical trial regulatory documentation for pharmaceutical companies. Its platform automates data analysis and narrative authoring to speed up drug trial documentation and regulatory approvals.

1 investor

Natac is a company focused on natural products research that organizes the Premios Nacionales de Investigación Natac, national awards recognizing scientific work on bioactive compounds and natural product extraction.

1 investor

1 investor

Naturacare is a full-service CDMO (contract development and manufacturing organization) that designs, develops, and produces natural health products and dietary supplements for both humans and animals. It offers dosage form development, custom formulations, ingredient sourcing, and eco-designed packaging for brands across various distribution channels, operating five production sites in Europe.

1 investor

Natural Trace develops a food-grade, DNA-based tagging system (NaturalTag) with a detection kit (NaturalDetect) and a digital platform (NaturalCloud) to authenticate food products and trace them through the supply chain. It serves food producers and ingredient owners seeking in-product traceability, provenance verification, and regulatory compliance.

1 investor

ApiSave develops diagnostic and treatment solutions for honeybee health, targeting beekeepers and agricultural organizations concerned with protecting bee populations and food system sustainability.

1 investor

NAV Vaccine develops preventive and therapeutic drugs using immune system technology. The company focuses on cancer treatments, immunotherapy combination therapies, viral prevention vaccines, and tissue regeneration therapeutics.

1 investor

Navega Therapeutics develops gene therapies using zinc-finger and CRISPR-based epigenome regulation to control gene expression. The company works in the biotech and gene therapy space.

1 investor

Develops antibodies for treating autoimmune diseases.

1 investor

Navigene develops AI-enabled diagnostic tests using proprietary processes and lab automation, focusing on accurate, affordable, next-generation diagnostics. It serves patients by offering precise testing along with disease management counseling.

1 investor

Navignostics analyzes tumor samples using highly multiplex imaging mass cytometry and proprietary computational workflows to characterize tumors at the single-cell level, producing reports that help clinicians select personalized cancer therapies and help researchers develop new drugs. It is a spin-off from the University of Zurich Bodenmiller Lab serving oncology clinicians and cancer researchers.

1 investor

1 investor